Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma

Overexpression of High-Mobility Group Box 2 Is Associated with Tumor Aggressiveness and Prognosis of Hepatocellular Carcinoma

(2010) J.-H. Kwon et al.   CLINICAL CANCER RESEARCH

Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer

(2010) Diego F. Calvisi et al.   JOURNAL OF HEPATOLOGY

An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB

(2010) Junxia Min et al.   NATURE MEDICINE

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis

(2010) D. Xie et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis

(2009) D. Xie et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis

(2008) Jing Yang et al.   DEVELOPMENTAL CELL

Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients

(2008) Yi Ding et al.   INTERNATIONAL JOURNAL OF CANCER

Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma

(2008) Jun Zhou et al.   INTERNATIONAL JOURNAL OF CANCER